S&P TSX Capped Composite...

US Dollar vs CAD

Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

Get Started

CVGR

Covalent (CVGR)

Covalent

Date:

Regulatory News

Text Search:

Sort by:

Non-Regulatory News

Showing the most relevant articles for your search:NASDAQ:CVGR

1 2 3 Next >>

Date	Time	Source	Headline	Symbol	Company
10/30/2006	10:34AM	Business Wire	Covalent Group Changes Name to Encorium Group, Inc.	NASDAQ:CVGR	Covalent
10/20/2006	3:08PM	Business Wire	Covalent Group, Inc. Announces Results of Shareholder Vote	NASDAQ:CVGR	Covalent
10/19/2006	7:01AM	Business Wire	Covalent Signs $8.2 Million in Contracts For Multinational Studies to Treat Influenza	NASDAQ:CVGR	Covalent
08/08/2006	3:36PM	Business Wire	Covalent Reports 2006 Second Quarter Financial Results; Company to Hold Conference Call at 9:00 AM on Wednesday, August 9, 2006	NASDAQ:CVGR	Covalent
08/07/2006	7:24AM	Business Wire	Covalent Group, Inc. Announces $1.7 Million Contract For Phase 2 Clinical Trial in Atherosclerosis	NASDAQ:CVGR	Covalent
08/02/2006	9:14AM	Business Wire	Covalent Group, Inc. Schedules Second Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
07/13/2006	11:00AM	Business Wire	Covalent Group, Inc. Signs Contracts Totaling $1.5 Million for Clinical Studies Offering Advanced Therapeutic Approaches to Pat	NASDAQ:CVGR	Covalent
07/06/2006	1:15PM	Business Wire	Covalent Group Amends Business Combination Agreement with Remedium Oy	NASDAQ:CVGR	Covalent
06/28/2006	7:27AM	Business Wire	Covalent Group, Inc. Announces $2.1 Million of New Business Contracts; Reiterates Second Quarter Guidance	NASDAQ:CVGR	Covalent
05/15/2006	4:22PM	Business Wire	Covalent Reports 2006 First Quarter Financial Results and Summary Balance Sheet Data; Company to Hold Conference Call at 9:00 A	NASDAQ:CVGR	Covalent
05/08/2006	7:12AM	Business Wire	Covalent Group, Inc. Schedules First Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
04/20/2006	7:07AM	Business Wire	Covalent Group, Inc. Signs $1 Million Contract To Conduct Phase 1 Study of Drug to Prevent/Treat Infectious Disease	NASDAQ:CVGR	Covalent
03/30/2006	7:00AM	Business Wire	Covalent Group, Inc. Announces Additional New Business Contracts	NASDAQ:CVGR	Covalent
03/21/2006	4:15PM	Business Wire	Covalent Group, Inc. Announces $2.1 Million Contract To Conduct Patient Disease Registry In Hospitalized Subjects With Hyponatr	NASDAQ:CVGR	Covalent
03/21/2006	4:14PM	Business Wire	Covalent Group, Inc. Signs $1.3 Million in Consulting and Medical Writing Contracts to Support New Drug Applications (NDA) for	NASDAQ:CVGR	Covalent
03/21/2006	4:12PM	Business Wire	Covalent Reports 2005 Fourth Quarter and Year End Financial Results and Summary Balance Sheet Data; Company to Hold Conference	NASDAQ:CVGR	Covalent
03/16/2006	6:57AM	Business Wire	Covalent Group, Inc. Schedules Fourth Quarter Financial Results and Conference Call	NASDAQ:CVGR	Covalent
03/03/2006	7:12AM	Business Wire	Covalent Group, Inc. Enters into Combination Agreement with Remedium Oy; Conference Call Scheduled for 11:00 AM ET Today	NASDAQ:CVGR	Covalent
02/08/2006	8:31AM	Business Wire	Covalent Group, Inc. and Sudler & Hennessey Announce Strategic Partnership to Design and Conduct Global Patient Disease Registri	NASDAQ:CVGR	Covalent
02/02/2006	7:01AM	Business Wire	Covalent Group, Inc. Signs $2.2 Million Contract With New Sponsor to Conduct Clinical Trial in Patients with Cardiovascular Dise	NASDAQ:CVGR	Covalent
01/31/2006	11:00AM	Business Wire	Covalent Group, Inc. Retains The Equity Group to Provide Investor Relations Services	NASDAQ:CVGR	Covalent
01/24/2006	7:00AM	PR Newswire (US)	Covalent Group, Inc. Announces Multiple New Business Contracts with an Aggregate Value of $1.0 Million	NASDAQ:CVGR	Covalent
01/18/2006	7:00AM	PR Newswire (US)	Covalent Group, Inc. Signs Contract for $2.3 Million to Conduct a Multinational Phase 2 Clinical Trial Involving a New Antithrom	NASDAQ:CVGR	Covalent
12/08/2005	6:00AM	PR Newswire (US)	Covalent Group, Inc. Signs Letter-of-Intent to Conduct $2.2 Million Multinational Phase 2 Clinical Trial in Cardiovascular Disea	NASDAQ:CVGR	Covalent
12/05/2005	6:01AM	PR Newswire (US)	Covalent Group, Inc. and Emergent BioSolutions Sign Contract to Develop Immune Globulins for Treatment Exposure of Anthrax Infec	NASDAQ:CVGR	Covalent
11/18/2005	8:30AM	PR Newswire (US)	CSC's DVC Reaches Milestone in Plague Vaccine Clinical Trial	NASDAQ:CVGR	Covalent
11/11/2005	9:20AM	PR Newswire (US)	/C O R R E C T I O N -- Covalent Group, Inc. /	NASDAQ:CVGR	Covalent
11/10/2005	4:01PM	PR Newswire (US)	Covalent Reports Results for Third Quarter 2005	NASDAQ:CVGR	Covalent
11/07/2005	7:03AM	PR Newswire (US)	Covalent Group, Inc. to Report Third Quarter 2005 Results on Thursday, November 10	NASDAQ:CVGR	Covalent
10/06/2005	8:01AM	PR Newswire (US)	Covalent Group, Inc. Announces $5.3 Million Contract to Provide Additional Services for a Global Phase 3 Trial in Hypertension	NASDAQ:CVGR	Covalent

Showing the most relevant articles for your search:NASDAQ:CVGR

1 2 3 Next >>

Amundi Index Solutions

Belgium Tf 1,4% Gn53 Eur

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions